The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Body Mass Index in 1.2 Million Adolescents and Risk for End-Stage Renal Disease
Open accessAbstract
BACKGROUND: The relationship between adolescent body mass index (BMI) and future risk for end-stage renal disease (ESRD) is not fully understood, nor is it known the extent to which this association is limited to diabetic ESRD. We evaluated the association between BMI in adolescence and the risk for all-cause, diabetic, and nondiabetic ESRD. METHODS: Medical data about 1 194 704 adolescents aged 17 years who had been examined for fitness for military service between January 1, 1967, and December 31, 1997, were linked to the Israeli ESRD registry in this nationwide population-based retrospective cohort study. Incident cases of treated ESRD between January 1, 1980, and May 31, 2010, were included. Cox proportional hazards models were used to estimate the hazard ratio (HR) for treated ESRD among study participants for their BMI at age 17 years, defined in accord with the US Centers for Disease Control and Prevention BMI for age and sex classification. RESULTS: During 30 478 675 follow-up person-years (mean [SD], 25.51 [8.77] person-years), 874 participants (713 male and 161 female) developed treated ESRD, for an overall incidence rate of 2.87 cases per 100 000 person-years. Compared with adolescents of normal weight, overweight adolescents (85th to 95th percentiles of BMI) and obese adolescents (≥95th percentile of BMI) had an increased future risk for treated ESRD, with incidence rates of 6.08 and 13.40 cases per 100 000 person-years, respectively. In a multivariate model adjusted for sex, country of origin, systolic blood pressure, and period of enrollment in the study, overweight was associated with an HR of 3.00 (95% CI, 2.50-3.60) and obesity with an HR of 6.89 (95% CI, 5.52-8.59) for all-cause treated ESRD. Overweight (HR, 5.96; 95% CI, 4.41-8.06) and obesity (HR, 19.37; 95% CI, 14.13-26.55) were strong and independent risk factors for diabetic ESRD. Positive associations of overweight (HR, 2.17; 95% CI, 1.71-2.74) and obesity (HR, 3.41; 95% CI, 2.42-4.79) with nondiabetic ESRD were also documented. CONCLUSIONS: Overweight and obesity in adolescents were associated with significantly increased risk for all-cause treated ESRD during a 25-year period. Elevated BMI constitutes a substantial risk factor for diabetic and nondiabetic ESRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000
Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Strawn, L. G., Flegal, K. M., & Mei, Z. (2002) · Cited by 6,426
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Prevalence of Overweight and Obesity in the United States
Crespo, C. J., & Ellen, S. (2003) · Obesity: Etiology Assessment Treatment and Prevention · doi:10.5040/9781718206601.ch-001 · Cited by 4,379
Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Ogden, C. L. (2002) · JAMA · doi:10.1001/jama.288.14.1728 · Cited by 4,060
2000 CDC Growth Charts for the United States: methods and development.
Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Grummer‐Strawn, L. M., Flegal, K. M., Mei, Z., Wei, R. X., Curtin, L. R., Roche, A. F., & Johnson, C. L. (2002) · PubMed · Cited by 3,716
Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008
Ogden, C. L. (2010) · JAMA · doi:10.1001/jama.2009.2012 · Cited by 3,200
High body mass index for age among US children and adolescents, 2003-2006.
Ogden, C. L. (2008) · JAMA · doi:10.1001/jama.299.20.2401 · Cited by 1,850
Do Obese Children Become Obese Adults? A Review of the Literature
Serdula, M. K., Ivery, D., Coates, R. J., Freedman, D. S., Williamson, D. F., & Byers, T. (1993) · Preventive Medicine · doi:10.1006/pmed.1993.1014 · Cited by 1,798
Body Mass Index and Risk for End-Stage Renal Disease
Hsu, C.-Y., McCulloch, C. E., Iribarren, C., Darbinian, J., & Go, A. S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-1-200601030-00006 · Cited by 1,390
Obesity-related glomerulopathy: An emerging epidemic
Kambham, N., Markowitz, G. S., Valeri, A. M., Lin, J., & D'Agati, V. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041498.x · Cited by 1,286
Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.7.844 · Cited by 1,241
Wolf, G., Chen, S., Han, D. C., & Ziyadeh, F. N. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.29865 · Cited by 871
Adolescent BMI Trajectory and Risk of Diabetes versus Coronary Disease
Tirosh, A., Shai, I., Afek, A., Dubnov-Raz, G., Ayalon, N., Gordon, B., Derazne, E., Tzur, D., Shamis, A., Vinker, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1006992 · Cited by 705
Self-citationObesity and Risk for Chronic Renal Failure
Ejerblad, E., Fored, C. M., Lindblad, P., Fryzek, J., McLaughlin, J. K., & Nyrén, O. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005060638 · Cited by 680
Tuck, M. L., Sowers, J., Dornfeld, L., Kledzik, G., & Maxwell, M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104163041602 · Cited by 643
Glomerular hemodynamics in severe obesity
Chagnac, A., Weinstein, T., Korzets, A., Ramadan, E., Hirsch, J., & Gafter, U. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.5.f817 · Cited by 614
Body mass index and the risk of development of end-stage renal disease in a screened cohort
Iseki, K., Ikemiya, Y., Kinjo, K., Inoue, T., Iseki, C., & Takishita, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00582.x · Cited by 603
Risk Factors for End-Stage Renal Disease: 25-Year Follow-up
Hsu, C.-Y., Iribarren, C., McCulloch, C. E., Darbinian, J., & Go, A. S. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.605 · Cited by 589
Association Between Body Mass Index and CKD in Apparently Healthy Men
Gelber, R. P., Kurth, T., Kausz, A. T., Manson, J. E., Buring, J. E., Levey, A. S., & Gaziano, J. M. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.08.015 · Cited by 460
Association of Adolescent Obesity With Risk of Severe Obesity in Adulthood
The, N. S., Suchindran, C., North, K. E., Popkin, B. M., & Gordon-Larsen, P. (2010) · JAMA · doi:10.1001/jama.2010.1635 · Cited by 458
Obesity and Prevalent and Incident CKD: The Hypertension Detection and Follow-Up Program
Kramer, H., Luke, A., Bidani, A., Cao, G., Cooper, R., & McGee, D. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.06.007 · Cited by 414
Tracking of overweight status from childhood to young adulthood: the Bogalusa Heart Study
Deshmukh-Taskar, P., Nicklas, T. A., Morales, M., Yang, S.-J., Zakeri, I., & Berenson, G. S. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602266 · Cited by 391
Early Predictors of 15-Year End-Stage Renal Disease in Hypertensive Patients
Perry, H. M., Miller, J. P., Fornoff, J. R., Baty, J. D., Sambhi, M. P., Rutan, G., Moskowitz, D. W., & Carmody, S. E. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.587 · Cited by 347
The Nephrotic Syndrome: A Complication of Massive Obesity
WEISINGER, J. R., KEMPSON, R. L., ELDRIDGE, F. L., & SWENSON, R. S. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-440 · Cited by 318
Brancati, F. L. (1997) · JAMA · doi:10.1001/jama.278.23.2069 · Cited by 272
Heterogeneous nature of renal lesions in type II diabetes.
Gambara, V, Mecca, G., Remuzzi, G., & Bertani, T. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v381458 · Cited by 257
Vivante, A. (2011) · JAMA · doi:10.1001/jama.2011.1141 · Cited by 222
Self-citationGiacchetti, G., Faloia, E., Mariniello, B., Sardu, C., Gatti, C., Camilloni, M. A., Guerrieri, M., & Mantero, F. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02257-4 · Cited by 202
Abelson, P., & Kennedy, D. (2004) · Science · doi:10.1126/science.304.5676.1413 · Cited by 198
Prevalence of chronic kidney disease
Bellizzi, V. (2008) · Giornale Italiano di Nefrologia · Cited by 176
ACE Inhibition Is Renoprotective among Obese Patients with Proteinuria
Mallamaci, F., Ruggenenti, P. L., Perna, A., Leonardis, D., Tripepi, R., Tripepi, G., Remuzzi, G., & Zoccali, C. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010090969 · Cited by 158
Munkhaugen, J., Lydersen, S., Widerøe, T., & Hallan, S. I. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.03.023 · Cited by 150
Risk Factors for Proteinuria in a Large, Multiracial, Southeast Asian Population
Ramirez, S. P. B., McClellan, W., Port, F. K., & Hsu, S. I. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000018406.20282.c8 · Cited by 144
Body Mass Index and Risk for End-Stage Renal Disease
Hsu, C., Iribarren, C., & Go, A. S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-9-200605020-00022 · Cited by 113
Obesity-Related Glomerulopathy in China: A Case Series of 90 Patients
Chen, H., Li, S., Chen, H., Wang, Q., Leishi, L., & Liu, Z.-H. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.303 · Cited by 106
Body mass index and risk of ESRD in China.
Reynolds, K., Gu, D., Muntner, P., Chen, J., Wu, X.-G., Yau, C., Duan, X.-F., Chen, C.-S., Hamm, L., & He, J. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.08.011 · Cited by 57
Molecular basis of renal disease. Molecular studies of leptin: implications for renal disease
Stenvinkel, P., Lönnqvist, F., & Schalling, M. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.5.1103 · Cited by 55
Prehypertension and Obesity in AdolescentsA Population Study
Israeli, E., SCHOCHAT, T., Korzets, Z., Tekes-Manova, D., Bernheim, J., & Golan, E. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.01.012 · Cited by 52
Self-citationPredictors of end-stage renal disease and body mass index in a screened cohort.
Iseki, K., Ikemiya, Y., & Fukiyama, K. (1997) · PubMed · Cited by 42
Adolescent BMI Trajectory and Risk of Diabetes versus Coronary Disease
Gersh, B. J. (2012) · Yearbook of Cardiology · doi:10.1016/j.ycar.2012.01.080 · Cited by 24
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
Kovesdy, C. P., Furth, S. L., Zoccali, C., & on behalf of the World Kidney Day Steering Committee (2017) · American Journal of Nephrology · doi:10.1159/000458467 · Cited by 2,217
Herrington, W., Lacey, B., Sherliker, P., Armitage, J., & Lewington, S. (2016) · Circulation Research · doi:10.1161/circresaha.115.307611 · Cited by 1,469
Romagnani, P., Remuzzi, G., Glassock, R., Levin, A., Jager, K. J., Tonelli, M., Massy, Z., Wanner, C., & Anders, H.-J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.88 · Cited by 996
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate
Grams, M. E., Sang, Y., Levey, A. S., Matsushita, K., Ballew, S., Chang, A. R., Chow, E. K. H., Kasiske, B. L., Kovesdy, C. P., Nadkarni, G. N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510491 · Cited by 454
Metadata
- Authors
- Vivante, A., Golan, E., Tzur, D., Leiba, A., Tirosh, A., Skorecki, K., & Calderon-Margalit, R.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2012-11-26
- Volume
- 172
- Issue
- 21
- Pages
- 1644
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2019071861
- Cited by
- 321
- References
- 42
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.